Annual CFF:
-$5.24B+$825.72M(+13.61%)Summary
- As of today, GSK annual cash from financing is -$5.24 billion, with the most recent change of +$825.72 million (+13.61%) on December 31, 2024.
- During the last 3 years, GSK annual cash from financing has risen by +$4.14 billion (+44.14%).
- GSK annual cash from financing is now -206.96% below its all-time high of $4.90 billion, reached on December 31, 2018.
Performance
GSK Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly CFF:
-$2.78B-$4.02B(-323.90%)Summary
- As of today, GSK quarterly cash from financing is -$2.78 billion, with the most recent change of -$4.02 billion (-323.90%) on June 30, 2025.
- Over the past year, GSK quarterly cash from financing has dropped by -$1.12 billion (-67.66%).
- GSK quarterly cash from financing is now -123.89% below its all-time high of $11.63 billion, reached on June 30, 2018.
Performance
GSK Quarterly Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFF:
-$3.92B-$1.12B(-40.03%)Summary
- As of today, GSK TTM cash from financing is -$3.92 billion, with the most recent change of -$1.12 billion (-40.03%) on June 30, 2025.
- Over the past year, GSK TTM cash from financing has increased by +$5.22 billion (+57.11%).
- GSK TTM cash from financing is now -138.76% below its all-time high of $10.11 billion, reached on March 31, 2019.
Performance
GSK TTM Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
GSK Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +13.6% | -67.7% | +57.1% |
| 3Y3 Years | +44.1% | +51.3% | -3476.1% |
| 5Y5 Years | -338.1% | +1.2% | +68.4% |
GSK Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -355.9% | +44.1% | -323.9% | +31.6% | -292.9% | +57.1% |
| 5Y | 5-Year | -355.9% | +55.9% | -125.7% | +51.3% | -222.7% | +68.5% |
| All-Time | All-Time | -207.0% | +55.9% | -123.9% | +51.3% | -138.8% | +68.5% |
GSK Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$2.78B(-323.9%) | -$3.92B(-40.0%) |
| Mar 2025 | - | $1.24B(+246.8%) | -$2.80B(+47.1%) |
| Dec 2024 | -$5.24B(+13.6%) | -$845.20M(+45.1%) | -$5.29B(+37.8%) |
| Sep 2024 | - | -$1.54B(+7.1%) | -$8.51B(+6.9%) |
| Jun 2024 | - | -$1.66B(-32.1%) | -$9.14B(-29.8%) |
| Mar 2024 | - | -$1.25B(+69.1%) | -$7.04B(-16.6%) |
| Dec 2023 | -$6.07B(-396.3%) | -$4.06B(-87.5%) | -$6.04B(-83.7%) |
| Sep 2023 | - | -$2.17B(-592.9%) | -$3.29B(-14.7%) |
| Jun 2023 | - | $439.58M(+276.5%) | -$2.87B(+68.2%) |
| Mar 2023 | - | -$249.08M(+81.0%) | -$9.01B(-543.3%) |
| Dec 2022 | $2.05B(+121.8%) | -$1.31B(+24.9%) | $2.03B(>+9900.0%) |
| Sep 2022 | - | -$1.75B(+69.4%) | $14.09M(+112.8%) |
| Jun 2022 | - | -$5.70B(-152.8%) | -$109.63M(-103.4%) |
| Mar 2022 | - | $10.79B(+424.2%) | $3.19B(+134.1%) |
| Dec 2021 | -$9.39B(+21.1%) | -$3.33B(-78.0%) | -$9.37B(-9.4%) |
| Sep 2021 | - | -$1.87B(+22.0%) | -$8.57B(+28.7%) |
| Jun 2021 | - | -$2.40B(-35.0%) | -$12.02B(+3.3%) |
| Mar 2021 | - | -$1.78B(+29.7%) | -$12.43B(-4.6%) |
| Dec 2020 | -$11.89B(-893.5%) | -$2.53B(+52.5%) | -$11.88B(+4.3%) |
| Sep 2020 | - | -$5.32B(-89.1%) | -$12.42B(-31.8%) |
| Jun 2020 | - | -$2.81B(-129.5%) | -$9.42B(-28.5%) |
| Mar 2020 | - | -$1.23B(+60.0%) | -$7.33B(-518.4%) |
| Dec 2019 | -$1.20B(-124.4%) | -$3.06B(-32.1%) | -$1.19B(+43.6%) |
| Sep 2019 | - | -$2.32B(-220.3%) | -$2.10B(+5.9%) |
| Jun 2019 | - | -$724.11M(-114.7%) | -$2.23B(-122.1%) |
| Mar 2019 | - | $4.92B(+223.6%) | $10.11B(+105.0%) |
| Dec 2018 | $4.90B(+168.1%) | -$3.98B(-62.3%) | $4.93B(-5.4%) |
| Sep 2018 | - | -$2.45B(-121.1%) | $5.22B(-23.5%) |
| Jun 2018 | - | $11.63B(+4567.5%) | $6.82B(+219.9%) |
| Mar 2018 | - | -$260.23M(+93.0%) | -$5.69B(+20.8%) |
| Dec 2017 | -$7.20B(+6.3%) | -$3.70B(-334.8%) | -$7.18B(-55.3%) |
| Sep 2017 | - | -$850.57M(+2.9%) | -$4.62B(+36.7%) |
| Jun 2017 | - | -$876.28M(+50.1%) | -$7.30B(+5.2%) |
| Mar 2017 | - | -$1.75B(-53.8%) | -$7.70B(-0.2%) |
| Dec 2016 | -$7.69B(+20.2%) | -$1.14B(+67.7%) | -$7.69B(+6.5%) |
| Sep 2016 | - | -$3.53B(-176.4%) | -$8.22B(-18.8%) |
| Jun 2016 | - | -$1.28B(+26.5%) | -$6.92B(+21.7%) |
| Mar 2016 | - | -$1.74B(-3.9%) | -$8.84B(+8.7%) |
| Dec 2015 | -$9.64B(-25.1%) | -$1.67B(+25.0%) | -$9.68B(+4.6%) |
| Sep 2015 | - | -$2.23B(+30.2%) | -$10.14B(-24.8%) |
| Jun 2015 | - | -$3.20B(-24.1%) | -$8.13B(-32.3%) |
| Mar 2015 | - | -$2.58B(-20.5%) | -$6.14B(+7.2%) |
| Dec 2014 | -$7.70B(+0.4%) | -$2.14B(-894.5%) | -$6.62B(+0.8%) |
| Sep 2014 | - | -$214.98M(+82.3%) | -$6.67B(+16.4%) |
| Jun 2014 | - | -$1.21B(+60.3%) | -$7.98B(+16.2%) |
| Mar 2014 | - | -$3.05B(-39.3%) | -$9.52B(-23.2%) |
| Dec 2013 | -$7.73B(-90.7%) | -$2.19B(-43.4%) | -$7.73B(-17.1%) |
| Sep 2013 | - | -$1.53B(+44.5%) | -$6.60B(+4.3%) |
| Jun 2013 | - | -$2.75B(-118.2%) | -$6.90B(-97.9%) |
| Mar 2013 | - | -$1.26B(-18.8%) | -$3.49B(+14.0%) |
| Dec 2012 | -$4.05B(+53.7%) | -$1.06B(+41.9%) | -$4.06B(+8.6%) |
| Sep 2012 | - | -$1.83B(-375.9%) | -$4.44B(+19.8%) |
| Jun 2012 | - | $662.37M(+136.2%) | -$5.53B(+34.6%) |
| Mar 2012 | - | -$1.83B(-26.7%) | -$8.46B(+3.8%) |
| Dec 2011 | -$8.76B | -$1.45B(+50.5%) | -$8.80B(-1.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2011 | - | -$2.92B(-28.9%) | -$8.64B(-25.0%) |
| Jun 2011 | - | -$2.27B(-4.9%) | -$6.91B(+2.3%) |
| Mar 2011 | - | -$2.16B(-67.7%) | -$7.07B(+4.4%) |
| Dec 2010 | -$7.40B(-136.6%) | -$1.29B(-8.0%) | -$7.40B(+5.7%) |
| Sep 2010 | - | -$1.19B(+50.9%) | -$7.85B(-68.4%) |
| Jun 2010 | - | -$2.43B(+2.4%) | -$4.66B(+7.5%) |
| Mar 2010 | - | -$2.49B(-43.1%) | -$5.04B(-61.0%) |
| Dec 2009 | -$3.13B(+48.1%) | -$1.74B(-187.1%) | -$3.13B(+3.0%) |
| Sep 2009 | - | $2.00B(+171.2%) | -$3.23B(+62.8%) |
| Jun 2009 | - | -$2.81B(-383.2%) | -$8.67B(-662.6%) |
| Mar 2009 | - | -$580.56M(+68.4%) | -$1.14B(+81.1%) |
| Dec 2008 | -$6.02B(-107.9%) | -$1.84B(+46.8%) | -$6.02B(-303.6%) |
| Sep 2008 | - | -$3.45B(-172.9%) | -$1.49B(-172.3%) |
| Jun 2008 | - | $4.73B(+186.5%) | -$548.18M(+92.4%) |
| Mar 2008 | - | -$5.47B(-302.9%) | -$7.26B(-149.6%) |
| Dec 2007 | -$2.90B(+64.0%) | $2.70B(+207.6%) | -$2.91B(+60.3%) |
| Sep 2007 | - | -$2.50B(-26.3%) | -$7.32B(-12.6%) |
| Jun 2007 | - | -$1.98B(-77.7%) | -$6.50B(+11.9%) |
| Mar 2007 | - | -$1.12B(+35.0%) | -$7.37B(+7.7%) |
| Dec 2006 | -$8.05B(-83.9%) | -$1.72B(-2.0%) | -$7.99B(+15.8%) |
| Sep 2006 | - | -$1.68B(+41.1%) | -$9.49B(-3.3%) |
| Jun 2006 | - | -$2.86B(-64.7%) | -$9.18B(-128.7%) |
| Mar 2006 | - | -$1.73B(+46.0%) | -$4.02B(+8.5%) |
| Dec 2005 | -$4.38B(+22.9%) | -$3.21B(-133.0%) | -$4.39B(-142.4%) |
| Sep 2005 | - | -$1.38B(-159.7%) | -$1.81B(+33.4%) |
| Jun 2005 | - | $2.31B(+209.6%) | -$2.72B(+49.9%) |
| Mar 2005 | - | -$2.11B(-232.8%) | -$5.42B(+3.5%) |
| Dec 2004 | -$5.68B(-27.1%) | -$633.91M(+72.3%) | -$5.62B(-5.3%) |
| Sep 2004 | - | -$2.29B(-482.3%) | -$5.34B(-19.3%) |
| Jun 2004 | - | -$392.51M(+83.0%) | -$4.47B(+20.3%) |
| Mar 2004 | - | -$2.31B(-552.5%) | -$5.61B(-26.9%) |
| Dec 2003 | -$4.47B(+26.0%) | -$353.53M(+75.1%) | -$4.42B(+7.9%) |
| Sep 2003 | - | -$1.42B(+7.2%) | -$4.80B(-1.1%) |
| Jun 2003 | - | -$1.53B(-36.8%) | -$4.75B(+15.7%) |
| Mar 2003 | - | -$1.12B(-52.3%) | -$5.64B(+6.8%) |
| Dec 2002 | -$6.04B(-8.7%) | -$734.38M(+46.4%) | -$6.06B(+24.7%) |
| Sep 2002 | - | -$1.37B(+43.4%) | -$8.04B(-10.2%) |
| Jun 2002 | - | -$2.42B(-58.0%) | -$7.29B(-16.1%) |
| Mar 2002 | - | -$1.53B(+43.6%) | -$6.28B(-13.3%) |
| Dec 2001 | -$5.56B(-29.3%) | -$2.72B(-335.8%) | -$5.54B(-51.7%) |
| Sep 2001 | - | -$623.42M(+55.8%) | -$3.65B(-19.9%) |
| Jun 2001 | - | -$1.41B(-77.8%) | -$3.05B(-81.7%) |
| Mar 2001 | - | -$793.36M(+4.1%) | -$1.68B(-102.7%) |
| Dec 2000 | -$4.30B(-22.4%) | -$827.58M(-4812.2%) | -$827.58M(>-9900.0%) |
| Sep 2000 | - | -$16.85M(+57.2%) | $100.00(-100.0%) |
| Jun 2000 | - | -$39.35M(-170.0%) | $16.85M(-70.0%) |
| Mar 2000 | - | $56.19M | $56.19M |
| Dec 1999 | -$3.51B(-146.4%) | - | - |
| Dec 1998 | -$1.43B(+28.0%) | - | - |
| Dec 1997 | -$1.98B(+25.5%) | - | - |
| Dec 1996 | -$2.66B(-179.0%) | - | - |
| Dec 1995 | $3.36B(+5659.7%) | - | - |
| Jun 1994 | $58.39M(+108.1%) | - | - |
| Jun 1993 | -$718.86M(+56.2%) | - | - |
| Jun 1992 | -$1.64B(-265.1%) | - | - |
| Jun 1991 | -$449.64M | - | - |
FAQ
- What is GSK plc annual cash from financing?
- What is the all-time high annual cash from financing for GSK plc?
- What is GSK plc annual cash from financing year-on-year change?
- What is GSK plc quarterly cash from financing?
- What is the all-time high quarterly cash from financing for GSK plc?
- What is GSK plc quarterly cash from financing year-on-year change?
- What is GSK plc TTM cash from financing?
- What is the all-time high TTM cash from financing for GSK plc?
- What is GSK plc TTM cash from financing year-on-year change?
What is GSK plc annual cash from financing?
The current annual cash from financing of GSK is -$5.24B
What is the all-time high annual cash from financing for GSK plc?
GSK plc all-time high annual cash from financing is $4.90B
What is GSK plc annual cash from financing year-on-year change?
Over the past year, GSK annual cash from financing has changed by +$825.72M (+13.61%)
What is GSK plc quarterly cash from financing?
The current quarterly cash from financing of GSK is -$2.78B
What is the all-time high quarterly cash from financing for GSK plc?
GSK plc all-time high quarterly cash from financing is $11.63B
What is GSK plc quarterly cash from financing year-on-year change?
Over the past year, GSK quarterly cash from financing has changed by -$1.12B (-67.66%)
What is GSK plc TTM cash from financing?
The current TTM cash from financing of GSK is -$3.92B
What is the all-time high TTM cash from financing for GSK plc?
GSK plc all-time high TTM cash from financing is $10.11B
What is GSK plc TTM cash from financing year-on-year change?
Over the past year, GSK TTM cash from financing has changed by +$5.22B (+57.11%)